Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. THYROGEN (thyrotropine alfa)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

THYROGEN (thyrotropine alfa)

Medicine - Posted on Oct 30 2013 - Updated on Jun 12 2019
Active substance (DCI)
  • thyrotropine alfa
history (4)
  • 10/16/13

    THYROGEN (thyrotropine alfa)

    La Commission prend acte de ces modifications qui ne sont pas de nature à modifier ses précédentes évaluations. ...
    icône flèche
  • 10/19/05

    THYROGEN (thyrotropine alfa)

    THYROGEN (thyrotropine alfa)
    CAV :
    54321
    icône flèche
  • 3/16/05

    THYROGEN (thyrotropine alfa)

    THYROGEN (thyrotropine alfa)
    CAV :
    54321
    icône flèche
  • 7/10/02

    THYROGEN (thyrotropine alfa)

    THYROGEN (thyrotropine alfa)
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • V04CJ01
Manufacturer
GENZYME S.A.S.
Presentation

THYROGEN 0,9 mg, poudre pour solution injectable (code CIS : 68937442)
2 flacon(s) en verre - (Code CIP : 34009 357 770 5 8)

All our publications
    Biology (laboratory tests) Drug therapy Endocrine gland cancers Endocrine system diseases Medical imaging

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
g0D5VmnqSbBdEaPp